Curexo Inc. (060280.KQ)

KRW 9030.0

(1.46%)

Operating Expenses Summary of Curexo Inc.

  • Curexo Inc.'s latest annual operating expenses in 2023 was 18.16 Billion KRW , up 36.71% from previous year.
  • Curexo Inc.'s latest quarterly operating expenses in 2024 Q2 was 4.04 Billion KRW , down -8.37% from previous quarter.
  • Curexo Inc. reported a annual operating expenses of 12.3 Billion KRW in annual operating expenses 2022, up 18.59% from previous year.
  • Curexo Inc. reported a annual operating expenses of 10.37 Billion KRW in annual operating expenses 2021, up 24.86% from previous year.
  • Curexo Inc. reported a quarterly operating expenses of 4.04 Billion KRW for 2024 Q2, down -8.37% from previous quarter.
  • Curexo Inc. reported a quarterly operating expenses of 3.76 Billion KRW for 2023 Q1, up 3.77% from previous quarter.

Annual Operating Expenses Chart of Curexo Inc. (2023 - 2016)

Historical Annual Operating Expenses of Curexo Inc. (2023 - 2016)

Year Operating Expenses Operating Expenses Growth
2023 18.16 Billion KRW 36.71%
2022 12.3 Billion KRW 18.59%
2021 10.37 Billion KRW 24.86%
2020 8.3 Billion KRW -9.76%
2019 9.2 Billion KRW -11.31%
2018 10.38 Billion KRW 107.57%
2017 5 Billion KRW -88.1%
2016 42.05 Billion KRW 0.0%

Peer Operating Expenses Comparison of Curexo Inc.

Name Operating Expenses Operating Expenses Difference
Osang Healthcare Co.,Ltd 78.35 Billion KRW 76.821%
InBody Co.,Ltd 87.36 Billion KRW 79.21%
Seegene, Inc. 210.08 Billion KRW 91.354%
i-SENS, Inc. 91.12 Billion KRW 80.069%
Ray Co., Ltd. 59.03 Billion KRW 69.232%
Gencurix Inc. 12.79 Billion KRW -41.92%
Sugentech Inc. 18.6 Billion KRW 2.368%
L&C Bio Co., Ltd 25.86 Billion KRW 29.766%